WallStreetZenWallStreetZen

NASDAQ: GYRE
Gyre Therapeutics Inc Stock Ownership - Who owns Gyre Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Gyre Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Nassim UsmanDirector2024-04-0120,000$16.15
$323.00kSell
Nassim UsmanDirector2024-04-0120,000$6.93
$138.60kBuy
Nassim UsmanDirector2024-03-1520,000$17.26
$345.20kSell
Nassim UsmanDirector2024-03-1520,000$6.93
$138.60kBuy

1 of 1

GYRE insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GYRE insiders and whales buy or sell their stock.

GYRE Shareholders

What type of owners hold Gyre Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Gni Group Ltd82.26%70,272,408$1.15BInsider
Bvf Partners L P13.66%11,664,575$190.48MInsider
Iii Eugene A. Trainor9.16%7,827,024$127.82MInsider
Nea Partners 10 L P9.16%7,827,024$127.82MInsider
Investment 10 LLC7.22%6,171,669$100.78MInsider
C. Richard Kramlich5.35%4,572,845$74.67MInsider
M. James Barrett5.35%4,570,845$74.64MInsider
Peter J. Barris5.35%4,570,845$74.64MInsider
Scott D. Sandell5.35%4,569,845$74.63MInsider
Mark W. Perry5.35%4,567,512$74.59MInsider

1 of 3

GYRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GYRE0.37%99.63%Net BuyingNet Buying
PTGX79.94%20.06%Net SellingNet Selling
NMRA21.44%78.56%Net Buying
VCYT64.44%35.56%Net SellingNet Selling
ARDX38.01%61.99%Net SellingNet Selling
View Top Biotech Stocks

Gyre Therapeutics Stock Ownership FAQ

Who owns Gyre Therapeutics?

Gyre Therapeutics (NASDAQ: GYRE) is owned by 0.71% institutional shareholders, 189.84% Gyre Therapeutics insiders, and 0.00% retail investors. Gni Group Ltd is the largest individual Gyre Therapeutics shareholder, owning 70.27M shares representing 82.26% of the company. Gni Group Ltd's Gyre Therapeutics shares are currently valued at $1.20B.

If you're new to stock investing, here's how to buy Gyre Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.